Abstract
Oculocutaneous albinism (OCA) is a group of autosomal recessive disorders characterized by deficient synthesis of melanin pigment. Type I (tyrosinase-deficient) OCA results from mutations of the tyrosinase gene (TYR gene) encoding tyrosinase, the enzyme that catalyzes the first two steps of melanin biosynthesis. Mutations of the TYR gene have been identified in a large number of patients, most of Caucasian ethnic origin, with various forms of type I OCA. Here, we present an analysis of the TYR gene in eight Indo-Pakistani patients with type I OCA. We describe four novel TYR gene mutations and a fifth mutation previously observed in a Caucasian patient.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Giebel L. B., Musarella M. A., Spritz R. A. A nonsense mutation in the tyrosinase gene of Afghan patients with tyrosinase negative (type IA) oculocutaneous albinism. J Med Genet. 1991 Jul;28(7):464–467. doi: 10.1136/jmg.28.7.464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Giebel L. B., Spritz R. A. RFLP for MboI in the human tyrosinase (TYR) gene detected by PCR. Nucleic Acids Res. 1990 May 25;18(10):3103–3103. doi: 10.1093/nar/18.10.3103-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Giebel L. B., Strunk K. M., Spritz R. A. Organization and nucleotide sequences of the human tyrosinase gene and a truncated tyrosinase-related segment. Genomics. 1991 Mar;9(3):435–445. doi: 10.1016/0888-7543(91)90409-8. [DOI] [PubMed] [Google Scholar]
- King R. A., Mentink M. M., Oetting W. S. Non-random distribution of missense mutations within the human tyrosinase gene in type I (tyrosinase-related) oculocutaneous albinism. Mol Biol Med. 1991 Feb;8(1):19–29. [PubMed] [Google Scholar]
- LERNER A. B., FITZPATRICK T. B. Biochemistry of melanin formation. Physiol Rev. 1950 Jan;30(1):91–126. doi: 10.1152/physrev.1950.30.1.91. [DOI] [PubMed] [Google Scholar]
- Rinchik E. M., Bultman S. J., Horsthemke B., Lee S. T., Strunk K. M., Spritz R. A., Avidano K. M., Jong M. T., Nicholls R. D. A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism. Nature. 1993 Jan 7;361(6407):72–76. doi: 10.1038/361072a0. [DOI] [PubMed] [Google Scholar]
- Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
- Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spritz R. A., Holmes S. A., Ramesar R., Greenberg J., Curtis D., Beighton P. Mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene account for a continuous range of phenotypes in human piebaldism. Am J Hum Genet. 1992 Nov;51(5):1058–1065. [PMC free article] [PubMed] [Google Scholar]
- Spritz R. A. Molecular genetics of oculocutaneous albinism. Semin Dermatol. 1993 Sep;12(3):167–172. [PubMed] [Google Scholar]
- Tripathi R. K., Giebel L. B., Strunk K. M., Spritz R. A. A polymorphism of the human tyrosinase gene is associated with temperature-sensitive enzymatic activity. Gene Expr. 1991 May;1(2):103–110. [PMC free article] [PubMed] [Google Scholar]
- Tripathi R. K., Hearing V. J., Urabe K., Aroca P., Spritz R. A. Mutational mapping of the catalytic activities of human tyrosinase. J Biol Chem. 1992 Nov 25;267(33):23707–23712. [PubMed] [Google Scholar]
- Tripathi R. K., Strunk K. M., Giebel L. B., Weleber R. G., Spritz R. A. Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions. Am J Med Genet. 1992 Jul 15;43(5):865–871. doi: 10.1002/ajmg.1320430523. [DOI] [PubMed] [Google Scholar]